Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ana Laura Añe-Kouri"'
Autor:
Gisela María Suárez, Mauricio Catalá, Yadira Peña, Susana Portela, Ana Laura Añé-Kourí, Amnely González, Patricia Lorenzo-Luaces, Manuel Díaz, María de los A. Molina, Karla Pereira, Jenysbel de la C. Hernández, Mary Carmen Reyes, Nuris Ledón, Zaima Mazorra, Tania Crombet, Agustin Lage, Antonio Bencomo-Hernandez, Danay Saavedra
Publikováno v:
Exploration of Immunology, Vol 4, Iss 4, Pp 433-445 (2024)
Aim: Currently, malignant diseases represent a health issue worldwide. Among these, lung cancer is of growing importance, due to its high incidence and mortality. Chemotherapy, one of the most frequently used treatments, has shown its ability to indu
Externí odkaz:
https://doaj.org/article/0b6fbfbd307b4617a1722a3f7ca859ec
Autor:
Danay Saavedra, Ana Laura Añé-Kourí, Nir Barzilai, Calogero Caruso, Kyung-Hyun Cho, Luigi Fontana, Claudio Franceschi, Daniela Frasca, Nuris Ledón, Laura J. Niedernhofer, Karla Pereira, Paul D. Robbins, Alexa Silva, Gisela M. Suarez, Wim Vanden Berghe, Thomas von Zglinicki, Graham Pawelec, Agustín Lage
Publikováno v:
Immunity & Ageing, Vol 20, Iss 1, Pp 1-10 (2023)
Abstract Aging is a gradual, continuous series of natural changes in biological, physiological, immunological, environmental, psychological, behavioral, and social processes. Aging entails changes in the immune system characterized by a decrease in t
Externí odkaz:
https://doaj.org/article/4c145aa2e8744ecfa51288f777b2ec7a
Autor:
Danay Saavedra, Ana Laura Añé-Kourí, Naivy Sánchez, Lázaro Manuel Filgueira, Julio Betancourt, Carlos Herrera, Leniel Manso, Elibet Chávez, Armando Caballero, Carlos Hidalgo, Geydi Lorenzo, Meylan Cepeda, Carmen Valenzuela, Mayra Ramos, Kalet León, Zaima Mazorra, Tania Crombet
Publikováno v:
Immunity & Ageing, Vol 17, Iss 1, Pp 1-8 (2020)
Abstract Background Since the COVID-19 outbreak an unprecedented challenge for healthcare systems around the world has been placed. In Cuba, the first case of COVID-19 was reported on March 11. Elderly with multiple comorbidities have been the most r
Externí odkaz:
https://doaj.org/article/cc6578d157ba40c8873664470da11d33
Autor:
Gisela María Suárez, Mauricio Catalá, Yadira Peña, Susana Portela, Ana Laura Añé-Kourí, Amnely González, Patricia Lorenzo-Luaces, Manuel Díaz, María de los A. Molina, Karla Pereira, Jenysbel de la C. Hernández, Raúl Ramos, Mary Carmen Reyes, Nuris Ledón, Zaima Mazorra, Tania Crombet, Agustin Lage, Danay Saavedra
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Lung cancer is the second cause of cancer related deaths worldwide. Chemotherapy and immunotherapy represent the current standard of care for advanced NSCLC. Platinum-based chemotherapy expands late-differentiated T cell populations. Therefore, immun
Externí odkaz:
https://doaj.org/article/4386dbb52c084a3f8acdfe664662a93a
Autor:
José Jordán González, Danay Saavedra Hernández, Anselmo Abdo Cuza, Rafael Machado Martínez, Guillermo Pérez Aspuro, Juan Antonio Gutierrez Martínez, Mayra Ramos Suzarte, Tania Crombet Ramos, Ana Laura Añe-Kouri, Jonathan Pi Avila
Publikováno v:
Immunotherapy
Background: In COVID-19, EGFR production is upregulated in the alveolar epithelial cells. EGFR overexpression further activates STAT-3 and increases lung pathology. The EGFR pathway is also one of the major nodes in pulmonary fibrosis. Methods: Nimot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ce5ba1dd299ba146b11005e61962a01
https://doi.org/10.2217/imt-2021-0269
https://doi.org/10.2217/imt-2021-0269
Autor:
Kalet León, Danay Saavedra, Armando Caballero, Jorge Alain Caballero, Zaima Mazorra, Carlos Figueredo, Ana Laura Añe-Kouri, Naivy Sánchez, Carlos Herrera, Lázaro Manuel Filgueira, Julio Betancourt Cervantes, Mayra Ramos, Geidy Lorenzo, Jorge Berrio, Meylan Cepeda, Orlando Adolfo Lovelle, Tania Crombet
Publikováno v:
Immunotherapy
In COVID-19, the inflammatory cytokine-release syndrome is associated with the progression of the disease. Itolizumab is a monoclonal antibody that recognizes human CD6 expressed in activated T cells. The antibody has shown to be safe and efficacious
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6225684e2389cf8de5c2ffe1d3bad65e
https://doi.org/10.2217/imt-2020-0235
https://doi.org/10.2217/imt-2020-0235
Autor:
Nuris Ledón, Patricia Lorenzo-Luaces, Zaima Mazorra, Agustin Lage, Beatriz García, Eva Elena Salomón, Mauricio Catala, Leamnet Cordero, Tania Crombet, Malkon Guillermo Sánchez, Ana Laura Añe-Kouri, Karla Pereira, Elia Neninger, Gisela María Suárez, Danay Saavedra, Amnely González
Publikováno v:
Cancer Immunology, Immunotherapy. 70:1735-1743
Aging is considered the single most significant risk factor for the majority of common malignances including lung cancer. Together immunosenescence, changes occurring with aging in the immune system, and inflammaging, characterizes by a chronic, subc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a3bd75026ddab7dc870bd988e282eb1
https://doi.org/10.1007/s00262-020-02823-1
https://doi.org/10.1007/s00262-020-02823-1